Evidence map›Paper›PMID 26300525›Full record

ArticleEuropean journal of immunology2015

Syndecan-1 identifies and controls the frequency of IL-17-producing naïve natural killer T (NKT17) cells in mice.

Hong Dai, Ayesha Rahman, Ankit Saxena, Anil K Jaiswal, Abdiaziz Mohamood, Lourdes Ramirez, Sanjeev Noel, Hamid Rabb, Chunfa Jie, Abdel Rahim A Hamad

Open access · bronzeAbstract read
In one paragraph

Article in European journal of immunology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 35 citations in OpenAlex.

  1. Heparan Sulfate Proteoglycans in Immunity.Proteoglycan research · 2026
    Article
  2. Article
  3. Review
  4. Markers and makers of NKT17 cells.Experimental & molecular medicine · 2023
    Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. CD24Immune network · 2019
    Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Hong DaiDepartment of Pathology, Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Ayesha RahmanDepartment of Pathology, Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Ankit SaxenaDepartment of Pathology, Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Anil K JaiswalDepartment of Pathology, Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Abdiaziz MohamoodDepartment of Pathology, Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Lourdes RamirezDepartment of Pathology, Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Sanjeev NoelDepartment of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Hamid RabbDepartment of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Chunfa JieDepartment of Surgery, Feinberg School of Medicine, Northwestern University, Chicago, USA.
Abdel Rahim A HamadDepartment of Pathology, Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Johns Hopkins Medicine · USJohns Hopkins University · USNorthwestern University · US

Funding

Research BaseP30DK072488 · NIDDK · UNIVERSITY OF MARYLAND BALTIMORE · PI MITCHELL, BRAXTON D, TAYLOR, SIMEON I. · 2005 to 2019
$17.3M
Acute Kidney Injury and Double Negative T CellsR01DK104662 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI HAMAD, ABDEL RAHIM, RABB, HAMID · 2015 to 2023
$3.8M
Mechanisms of Fas Ligand Control of Insulitis in Autoimmune DiabetesR01AI099027 · NIAID · JOHNS HOPKINS UNIVERSITY · PI HAMAD, ABDEL RAHIM · 2013 to 2017
$2.0M
Acute Kidney Injury and Double Negative T CellsR21AI095484 · NIAID · JOHNS HOPKINS UNIVERSITY · PI HAMAD, ABDEL RAHIM, RABB, HAMID · 2012 to 2013
$446k
Mechanisms of Fas Ligand Control of Insulitis Initiation in Autoimmune DiabetesR56AI099027 · NIAID · JOHNS HOPKINS UNIVERSITY · PI HAMAD, ABDEL RAHIM · 2012 to 2012
$411k
NIAID NIH HHS AI099027NIAID NIH HHS R01 AI099027NIAID NIH HHS R21 AI095484NIAID NIH HHS R56 AI099027NIDDK NIH HHS P30 DK072488NIDDK NIH HHS P30DK072488NIDDK NIH HHS R01 DK104662
6 · The paper itself

Abstract

Invariant natural killer T (iNKT) cells recognize glycolipids as antigens and diversify into NKT1 (IFN-γ), NKT2 (IL-4), and NKT17 (IL-17) functional subsets while developing in the thymus. Mechanisms that govern the balance between these functional subsets are poorly understood due, partly, to the lack of distinguishing surface markers. Here we identify the heparan sulfate proteoglycan syndecan-1 (sdc1) as a specific marker of naïve thymic NKT17 cells in mice and show that sdc1 deficiency significantly increases thymic NKT17 cells at the expense of NKT1 cells, leading to impaired iNKT cell-derived IFN-γ, both in vitro and in vivo. Using surface expression of sdc1 to identify NKT17 cells, we confirm differential tissue localization and interstrain variability of NKT17 cells, and reveal that NKT17 cells express high levels of TCR-β, preferentially use Vβ8, and are more highly sensitive to ɑ-GalCer than to CD3/CD28 stimulation. These findings provide a novel, noninvasive, simple method for identification, and viable sorting of naïve NKT17 cells from unmanipulated mice, and suggest that sdc1 expression negatively regulates homeostasis in iNKT cells. In addition, these findings lay the groundwork for investigating the mechanisms by which sdc1 regulates NKT17 cells.

Indexed as

AnimalsCell SeparationGene Expression ProfilingInterleukin-17MiceMice, Inbred BALB CMice, Inbred C57BLNatural Killer T-CellsOligonucleotide Array Sequence AnalysisSyndecan-1T-Lymphocyte SubsetsInterleukin-17Sdc1 protein, mouseSyndecan-1alphaGalCerCD138IFN-γIL-17iNKT cellsSyndecan-1

Identifiers

PMID26300525
PMCPMC4676762
OpenAlexW1837020854

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.